The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for JHS Svendgaard Laboratories Ltd & Others
RETAIL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JHS Svendgaard Laboratories Ltd, part of the promoter group, acquired 10,00,000 fully convertible warrants of JHS Svendgaard Retail Ventures Ltd through a preferential allotment on May 23, 2025. The warrants represent 5.82% of the diluted share capital and are convertible into equity shares within 18 months. Before this, JHS Svendgaard Laboratories held no direct stake, while the Persons Acting in Concert (PACs — Nikhil Nanda, Harish Chander Nanda, Daljit Singh Grewal, Sushma Nanda) held 30,52,798 shares (44.86%) plus 9,71,357 warrants. After the acquisition, the combined promoter group holding rises to 40,53,798 instruments, equating to 44.86% of voting capital and 37.36% on a fully diluted basis. No shares were sold; only fresh warrants were added to the holdings.
The promoter group is reinforcing its control in the retail arm without diluting voting power immediately, as warrants carry no voting rights until conversion. Shareholders should note that if all promoter warrants are converted within 18 months, the group's effective equity stake could rise materially, pushing the promoter closer to majority control.